Buprenorphine via drinking water and combined oral-injection protocols for pain relief in mice

Applied Animal Behaviour Science

Volumn 185, Issue , 2016, Pages 103-112

  Sauer, Mareike ^a   Fleischmann, Thea ^a   Lipiski, Miriam ^a   Arras, Margarete ^a,b   Jirkof, Paulin ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Analgesia; Buprenorphine; Mouse; Oral administration; Pain; Refinement

Indexed keywords

BLOOD; BODY MASS; DRINKING WATER; DRUG; EXPERIMENTAL STUDY; FOOD INTAKE; RODENT; SERUM;

ANIMALIA; MUS;

EID: 84994408784     PISSN: 01681591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.applanim.2016.09.009     Document Type: Article

References (34)

1. Adamson, T.W., Kendall, L.V., Goss, S., Grayson, K., Touma, C., Palme, R., Chen, J.Q., Borowsky, A.D., Assessment of carprofen and buprenorphine on recovery of mice after surgical removal of the mammary fat pad. J. Am. Assoc. Lab. Anim. Sci. 49:5 (2010), 610–616.
2. Arras, M., Rettich, A., Cinelli, P., Kasermann, H.P., Burki, K., Assessment of post-laparotomy pain in laboratory mice by telemetric recording of heart rate and heart rate variability. BMC Vet. Res., 3, 2007, 16.
3. Bomzon, A., Are repeated doses of buprenorphine detrimental to postoperative recovery after laparotomy in rats?. Comp. Med. 56:2 (2006), 114–118.
4. Brewster, D., Humphrey, M.J., McLeavy, M.A., The systemic bioavailability of buprenorphine by various routes of administration. J. Pharm. Pharmacol. 33:8 (1981), 500–506.
5. Carbone, E.T., Lindstrom, K.E., Diep, S., Carbone, L., Duration of action of sustained-release buprenorphine in 2 strains of mice. J. Am. Assoc. Lab. Anim. Sci. 51:6 (2012), 815–819.
6. Christoph, T., Kogel, B., Schiene, K., Meen, M., De Vry, J., Friderichs, E., Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. Eur. J. Pharmacol. 507:1–3 (2005), 87–98.
7. Cinelli, P., Rettich, A., Seifert, B., Burki, K., Arras, M., Comparative analysis and physiological impact of different tissue biopsy methodologies used for the genotyping of laboratory mice. Lab. Anim. 41:2 (2007), 174–184.
8. Diehl, K.H., Hull, R., Morton, D., Pfister, R., Rabemampianina, Y., Smith, D., Vidal, J.M., van de Vorstenbosch, C., European Federation of Pharmaceutical Industries, A., European Centre for the Validation of Alternative, M., A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 21:1 (2001), 15–23.
9. Evans, H.C., Easthope, S.E., Transdermal buprenorphine. Drugs 63:19 (2003), 1999–2010 discussion 2011–1992.
10. Foley, P.L., Liang, H.X., Crichlow, A.R., Evaluation of a sustained-release formulation of buprenorphine for analgesia in rats. J. Am. Assoc. Lab. Anim. Sci. 50:2 (2011), 198–204.
11. Gades, N.M., Danneman, P.J., Wixson, S.K., Tolley, E.A., The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contemp. Top. Lab. Anim. Sci. 39:2 (2000), 8–13.
12. Goldkuhl, R., Jacobsen, K.R., Kalliokoski, O., Hau, J., Abelson, K.S., Plasma concentrations of corticosterone and buprenorphine in rats subjected to jugular vein catheterization. Lab. Anim. 44:4 (2010), 337–343.
13. Hayes, K.E., Raucci, J.A. Jr., Gades, N.M., Toth, L.A., An evaluation of analgesic regimens for abdominal surgery in mice. Contemp. Top. Lab. Anim. Sci. 39:6 (2000), 18–23.
14. Healy, J.R., Tonkin, J.L., Kamarec, S.R., Saludes, M.A., Ibrahim, S.Y., Matsumoto, R.R., Wimsatt, J.H., Evaluation of an improved sustained-release buprenorphine formulation for use in mice. Am. J. Vet. Res. 75:7 (2014), 619–625.
15. Heimann, M., Kasermann, H.P., Pfister, R., Roth, D.R., Burki, K., Blood collection from the sublingual vein in mice and hamsters: a suitable alternative to retrobulbar technique that provides large volumes and minimizes tissue damage. Lab. Anim. 43:3 (2009), 255–260.
16. Heimann, M., Roth, D.R., Ledieu, D., Pfister, R., Classen, W., Sublingual and submandibular blood collection in mice: a comparison of effects on body weight, food consumption and tissue damage. Lab. Anim. 44:4 (2010), 352–358.
17. Hovard, A., Teilmann, A., Hau, J., Abelson, K., The applicability of a gel delivery system for self-administration of buprenorphine to laboratory mice. Lab. Anim. 49:1 (2015), 40–45.
18. Institute of Laboratory Animal Resources (U.S.) Committee on Pain and Distress in Laboratory Animals (1992), Recognition and Alleviation of Pain and Distress in Laboratory Animals. Washington (DC). 1992, National Academy Press.
19. Jessen, L., Christensen, S., Bjerrum, O.J., The antinociceptive efficacy of buprenorphine administered through the drinking water of rats. Lab. Anim. 41:2 (2007), 185–196.
20. Jirkof, P., Cesarovic, N., Rettich, A., Fleischmann, T., Arras, M., Individual housing of female mice: influence on postsurgical behaviour and recovery. Lab. Anim. 46:4 (2012), 325–334.
21. Jirkof, P., Tourvieille, A., Cinelli, P., Arras, M., Buprenorphine for pain relief in mice: repeated injections vs sustained-release depot formulation. Lab. Anim. 49:3 (2015), 177–187.
22. Kalliokoski, O., Jacobsen, K.R., Hau, J., Abelson, K.S.P., Serum concentrations of buprenorphine after oral and parenteral administration in male mice. Vet. J. 187:2 (2011), 251–254.
23. Langford, D.J., Bailey, A.L., Chanda, M.L., Clarke, S.E., Drummond, T.E., Echols, S., Glick, S., Ingrao, J., Klassen-Ross, T., Lacroix-Fralish, M.L., Matsumiya, L., Sorge, R.E., Sotocinal, S.G., Tabaka, J.M., Wong, D., van den Maagdenberg, A.M., Ferrari, M.D., Craig, K.D., Mogil, J.S., Coding of facial expressions of pain in the laboratory mouse. Nat. Methods 7:6 (2010), 447–449.
24. Liles, J.H., Flecknell, P.A., Roughan, J., Cruz-Madorran, I., Influence of oral buprenorphine, oral naltrexone or morphine on the effects of laparotomy in the rat. Lab. Anim. 32:2 (1998), 149–161.
25. Mahler, M., Berard, M., Feinstein, R., Gallagher, A., Illgen-Wilcke, B., Pritchett-Corning, K., Raspa, M., FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units (vol 48, pg 178, 2014). Lab. Anim., 49(1), 2015 88–88.
26. Martin, L.B., Thompson, A.C., Martin, T., Kristal, M.B., Analgesic efficacy of orally administered buprenorphine in rats. Comp. Med. 51:1 (2001), 43–48.
27. Meijer, M.K., Spruijt, B.M., van Zutphen, L.F., Baumans, V., Effect of restraint and injection methods on heart rate and body temperature in mice. Lab. Anim. 40:4 (2006), 382–391.
28. Moberg, G.P., When does stress become distress?. Lab Anim. 28:4 (1999), 22–26.
29. Molina-Cimadevila, M.J., Segura, S., Merino, C., Ruiz-Reig, N., Andres, B., de Madaria, E., Oral self-administration of buprenorphine in the diet for analgesia in mice. Lab. Anim. 48:3 (2014), 216–224.
30. Roughan, J.V., Flecknell, P.A., Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals. Lab. Anim. 36:3 (2002), 322–343.
31. Thompson, A.C., Kristal, M.B., Sallaj, A., Acheson, A., Martin, L.B., Martin, T., Analgesic efficacy of orally administered buprenorphine in rats: methodologic considerations. Comp. Med. 54:3 (2004), 293–300.
32. Thompson, A.C., DiPirro, J.M., Sylvester, A.R., Martin, L.B., Kristal, M.B., Lack of analgesic efficacy in female rats of the commonly recommended oral dose of buprenorphine. J. Am. Assoc. Lab. Anim. Sci. 45:6 (2006), 13–16.
33. Worlein, J.M., Baker, K., Bloomsmith, M., Coleman, K., Koban, T.L., The eighth edition of the guide for the care and use of laboratory animals (2011); implications for behavioral management. Am. J. Primatol., 73, 2011 98–98.
34. Yassen, A., Olofsen, E., Dahan, A., Danhof, M., Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics. J. Pharmacol. Exp. Ther. 313:3 (2005), 1136–1149.